Comencemos
Hay varias opciones que pueden ayudarle a cubrir los gastos de su medicamento de Genentech. Responda a estas preguntas sencillas para averiguar cuál puede ser la adecuada para usted.
-
¿Tiene seguro médico?
-
¿Su seguro de salud cubre sus medicamentos de Genentech?
-
¿Tiene seguro médico comercial?
¿Qué significa esto? -
¿Está recibiendo alguna ayuda económica para poder pagar el medicamento?
¿Qué significa esto? -
¿Tiene 18 años de edad o más?
Puede que Reúna los Requisitos para que se le Derive a la Tarjeta de Copago de Genentech BioOncology
ZELBORAF Access Solutions puede derivarle a la Tarjeta de Copago de Genentech BioOncology. Si reúne los requisitos, puede ayudarle con los costos del bolsillo de su medicamento de Genentech.*
*Para poder optar a la Tarjeta de Copago de Genentech BioOncology, el paciente debe disponer de un seguro comercial, no debe tener Medicare, Medicaid ni ningún otro seguro público y debe cumplir otros criterios de elegibilidad. También debe aceptar las reglas establecidas en los términos y condiciones del programa. Visite CopayAssistanceNow.com para ver la lista completa de términos y condiciones.
Puede que Reúna los Requisitos para que se le Derive a una Fundación Independiente de Asistencia al Copago
Si necesita ayuda con el copago de su medicamento de Genentech, podemos derivarle a una fundación independiente de asistencia al copago.*
*Las fundaciones independientes de asistencia al copago tienen sus propias normas para la elegibilidad. No podemos garantizarle que una fundación le vaya a ayudar. Solo podemos derivarle para que esta le asista con su estado de salud. No respaldamos ni mostramos preferencia económica por ninguna fundación en particular. Las fundaciones a las que le derivemos no son las únicas que pueden ayudarle.
Puede que Reúna los Requisitos para que se le Derive a la Fundación Genentech Patient Foundation
Genentech Patient Foundation proporciona medicamentos gratuitos de Genentech a las personas que no tienen cobertura de seguro o que tienen problemas financieros, y a personas con determinado nivel de ingresos.*
*Si cuenta con cobertura de un seguro médico para su medicamento, primero debe haber probado otros tipos de asistencia a pacientes para ser apto para recibir medicamentos gratis de Genentech a través de Genentech Patient Foundation. Esto incluye la Tarjeta de Copago de Genentech BioOncology y la ayuda de fundaciones independientes de asistencia al copago. También debe cumplir otros criterios financieros. Si no tiene seguro o si su seguro no cubre su medicamento, debe cumplir unos criterios financieros diferentes.
Important Safety Information & Indication
What it Treats
What is ZELBORAF?
ZELBORAF is a prescription medicine used to treat a type of skin cancer called melanoma that has spread to other parts of the body or cannot be removed by surgery, and has a certain type of abnormal BRAF gene.
Your healthcare provider will perform a test to make sure that ZELBORAF is right for you. ZELBORAF is not used to treat melanoma with a normal BRAF gene.
ZELBORAF is a prescription medicine used to treat a type of blood cell cancer called Erdheim–Chester disease (ECD), that can affect body tissues and organs, and that has a certain type of abnormal “BRAF” gene.
Important Safety Information
ZELBORAF can cause serious side effects, including risk of new cancers. ZELBORAF may cause certain types of skin cancer called cutaneous squamous cell carcinoma (cuSCC) and keratoacanathoma. New melanoma lesions have occurred in people who take ZELBORAF. ZELBORAF may also cause another type of cancer called non-cutaneous squamous cell carcinoma (non-cuSCC). Talk with your healthcare provider about your risk for these cancers. Check your skin and tell your healthcare provider about skin changes, including a new wart, a sore or bump that bleeds or does not heal, or a mole that changes size or color.
Your healthcare provider should also check for cancers that may not occur on the skin. Tell your healthcare provider about any new symptoms that you get while taking ZELBORAF.
Other blood cancers have happened in some people with Erdheim-Chester Disease (ECD) including those who take ZELBORAF. If you have other blood cancers and take ZELBORAF for ECD, your healthcare provider will monitor your blood cancer through routine blood tests.
While taking ZELBORAF, you should avoid sunlight. When you go outside, wear clothes that protect your skin, including your head, face, hands, arms, and legs. Use lip balm and a broad-spectrum sunscreen with SPF 30 or higher.
Possible serious side effects of ZELBORAF include severe allergic reactions, severe skin reactions, potentially life-threatening changes in the electrical activity of your heart called QT prolongation, liver injury, eye problems, worsening side effects from radiation treatment, kidney injury, and connective tissue disorders.
Tell your healthcare provider if you are pregnant, or plan to become pregnant, as ZELBORAF can harm your unborn baby. Females who are able to become pregnant should use effective birth control during ZELBORAF treatment and for 2 weeks after the final dose.
Tell your healthcare provider if you are breastfeeding or plan to breastfeed. Do not breastfeed during treatment with ZELBORAF and for 2 weeks after the final dose. Talk to your healthcare provider about the best way to feed your baby during this time.
Tell your healthcare provider about all the medicines you take.
Common side effects of ZELBORAF include joint pain, rash, hair loss, tiredness, sunburn or sun sensitivity, nausea, itching, warts, or QT prolongation.
These are not all of the possible side effects of ZELBORAF. Call your doctor for medical advice about side effects.
You may report side effects to the FDA at (800) FDA-1088 or
www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555.
Please see accompanying Full Prescribing Information and Medication Guide for additional Important Safety Information.